Navigation Links
Prostate Cancer Discovered in 40 Percent of Men Who Test Negative for the Disease
Date:12/15/2008

WESTMONT, Ill., Dec. 15 /PRNewswire/ -- Forty percent of men with prostate cancer may not even know they have it, according to a new research study by the Prostate Cancer Foundation of Chicago. The study revealed the standard office biopsy procedure often isn't enough to properly detect prostate cancer. This new research will be published in an upcoming issue of Urology, a national medical journal.

Researchers used an advanced biopsy technique called stereotactic transperineal prostate biopsy (STPB). This was performed on patients with persistent elevated prostate specific antigen (PSA) levels who previously had at least one negative office biopsy. All patients had received transrectal prostate biopsies (TRPB), administered by a urologist.

"Men who have negative transrectal biopsies and continue to have elevated PSA levels should consider STPB because 40% will harbor malignancy," says Michelle Braccioforte, director of research and education for the Prostate Cancer Foundation of Chicago. "Our level of confidence is greatly enhanced with regards to the presence or absence of cancer, and more specifically, the exact location of the cancer within the prostate."

STPB is performed by taking a median of 40 samples of the prostate through the perineum while the patient is under general anesthesia. Performed as an outpatient procedure, it allows more comprehensive sampling, compared to the transrectal method, which takes fewer samples through the rectum. In addition, by taking more samples during STPB, the exact location of the cancer can be pinpointed.

Between April 2004 and January 2008, 747 patients with high PSA levels were studied. All patients had been tested using TRPB at least once and all results had been negative. All patients received the STPB. Biopsy results identified the presence of cancer in 291 (39%) of the patients.

One in six men in the U.S. will be diagnosed with prostate cancer, the most common form of cancer among men. For those with elevated or rising PSA levels, this is a sign that further testing should be administered to rule out prostate cancer.

The Prostate Cancer Foundation of Chicago, located in Westmont, IL, is a not-for-profit organization that conducts ongoing research intended to improve the diagnosis and treatment of prostate cancer. For more information, visit http://www.chicagoprostatefoundation.org to download or call Michelle at 630.654.2515.


'/>"/>
SOURCE The Prostate Cancer Foundation of Chicago
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. USAs largest ever prostate cancer screening program shows high compliance and consistent results
2. Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements
3. Hormone therapy for prostate cancer does not appear to increase cardiac deaths
4. Selenium, Vitamins E and C Wont Prevent Prostate Cancer
5. Study finds selenium, vitamin E do not prevent prostate cancer
6. Single Men Less Likely to Get Prostate Screens
7. Treatment Options Are Many for Prostate Cancer
8. ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
9. ESPNs Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
10. Prostate Cancer Stimulates Nerve Growth
11. Prostate cancer drug reduces testosterone levels in as little as 3 days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Charlottesville, Virginia (PRWEB) , ... January 18, 2017 , ... ... New studies are released almost daily linking gut health to chronic disease, mental health ... the New Year ” as an important resolution to consider. , For one Charlottesville ...
(Date:1/18/2017)... SHANGHAI, China – , ... ... public health organization NSF International has certified the first drinking ... 53: Drinking Water Treatment Units – Health Effects, an American ... that MicroCeramics’ NanoNose Pitcher Filter System filters the water to ...
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor ... Smile Train, an international charity that provides free surgery to poor children suffering from ... in the past I have run to support the efforts of the American Heart ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... offering asset protection and financial planning services to families and business owners in ... event aimed at supporting children with developmental disabilities. , The Lakemary Center is ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that Mr. Michael Merges, Director of Strategic Growth, ... be held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 18, 2017 ML Capital ... to publish an online presentation tomorrow, January 19 ... forecast for 2017. Management reports that the forecast ... sales performance from its existing operations, and the ... into the Cannabis sector through a partnership ...
(Date:1/18/2017)... 2017  Astellas Pharma Inc. (President and CEO: ... its participation in Access Accelerated, a global, multi-stakeholder ... prevention, diagnostics and treatment in low-income and lower-middle ... companies and in collaboration with the World Bank ... (UICC), Astellas will work towards the United Nations ...
(Date:1/17/2017)... 17, 2017 North America Insulin Delivery Market ... "North America Insulin Delivery Market Outlook to 2022", provides ... market. The report provides value, in millions of US ... market segments - Insulin Pens, Insulin Pumps, Insulin Syringes ... provides company shares and distribution shares data for each ...
Breaking Medicine Technology: